Cargando…
Blood-based Monitoring of Relapsed/Refractory Hodgkin Lymphoma Patients Predict Responses to Anti-PD-1 Treatment
Autores principales: | Drees, Esther E. E., Jauw, Yvonne W. S., van Dijk, Erik, Borchmann, Sven, Verkuijlen, Sandra A. W. M., Stathi, Phylicia, Groenewegen, Nils J., Hijmering, Nathalie J., Berry, Daniella R. A. I., Meershoek, Eric J., Hoogmoed, Danielle, Kwakman, Anne, Molenaar, Tessa J., Pegtel, Dirk M., Ylstra, Bauke, de Jong, Daphne, Zijlstra, Josée M., Roemer, Margaretha G. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257296/ https://www.ncbi.nlm.nih.gov/pubmed/35813096 http://dx.doi.org/10.1097/HS9.0000000000000749 |
Ejemplares similares
-
Multi-scale spatial modeling of immune cell distributions enables survival prediction in primary central nervous system lymphoma
por: Roemer, Margaretha G.M., et al.
Publicado: (2023) -
Extracellular vesicle miRNA predict FDG‐PET status in patients with classical Hodgkin Lymphoma
por: Drees, Esther E. E., et al.
Publicado: (2021) -
Blood‐circulating EV‐miRNAs, serum TARC, and quantitative FDG‐PET features in classical Hodgkin lymphoma
por: Drees, Esther E. E., et al.
Publicado: (2022) -
Engineering large-scale chromosomal deletions by CRISPR-Cas9
por: Eleveld, Thomas F, et al.
Publicado: (2021) -
The path towards consensus genome classification of diffuse large B-cell lymphoma for use in clinical practice
por: Mendeville, Matias, et al.
Publicado: (2022)